Innealta Capital’s ICU Medical ICUI Stock Holding History

Innealta Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-267	Closed	-$31.7K	–	873
2024 Q2	$31.7K	Buy	+267	New	+$28.1K	0.01%	488

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Innealta Capital's ICUI Position: Q3 2024 in Review

Innealta Capital sold out of ICU Medical (ICUI) in Q3 2024, closing a stake of 267 shares — an estimated $31.7K sold.

Innealta Capital first reported a position in ICUI in Q2 2024 and held it in 1 quarter. The position peaked at $31.7K in Q2 2024. 289 funds tracked by Wall St. Rank hold ICUI as of Q3 2024.

Innealta Capital reported no remaining ICU Medical position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 267 ICU Medical shares in Q3 2024, an estimated $31.7K.
Innealta Capital first reported a position in ICU Medical in Q2 2024 and held it in 1 quarter.
Innealta Capital's ICU Medical position peaked at $31.7K in Q2 2024.
289 funds tracked by Wall St. Rank held ICU Medical as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.